Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
NCT: NCT04761055 · COMPLETED
Brief Summary
This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination. The iBreastExam is a handheld device that performs a painless electronic palpation (examination by touch) of the breast. The device is designed to detect breast abnormalities that may require breast imaging and additional clinical examination by a nurse or doctor. The iBreastExam device creates a color map of the breast, with red spots indicating areas that may be abnormal.
Frequently Asked Questions
What is Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer?
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer is a clinical trial registered under NCT04761055. Current status: COMPLETED.
What is the status of NCT04761055?
The current status of NCT04761055 (Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer) is: COMPLETED.
When did Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer start?
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer started on 2021-01-29.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.